C785001

(R)-Crizotinib-d5 (piperidine-3,3,4,5,5-d5)

1395950-84-1

1874.06 €

HY-50878S

Crizotinib-d5

Crizotinib-d5 is the deuterium labeled Crizotinib. Crizotinib (PF-02341066) is an orally bioavailable, ATP-competitive ALK and c-Met inhibitor with IC50s of 20 and 8 nM, respectively. Crizotinib inhibits tyrosine phosphorylation of NPM-ALK and tyrosine phosphorylation of c-Met with IC50s of 24 and 11 nM in cell-based assays, respectively. Crizotinib is also a ROS1 inhibitor. Crizotinib has effective tumor growth inhibition[1][2][3].

669.03 €

MBS6053374-10mg

1-(Benzyl-d5)-4-piperidine-carboxaldehyde

862.92 €

MBS6075637-1mg

Acenocoumarol-d5 (4-Hydroxy-3-[1-(4-Nitrophenyl)-3-oxobutyl]-2H-1-benzopyran-2-one-d5, Acenocoumarin-d5, Nicoumalone-d5, G-23350-d5, Sinthrome-d5, Sintrom-d5)

965.94 €

MBS6075637-5x1mg

Acenocoumarol-d5 (4-Hydroxy-3-[1-(4-Nitrophenyl)-3-oxobutyl]-2H-1-benzopyran-2-one-d5, Acenocoumarin-d5, Nicoumalone-d5, G-23350-d5, Sinthrome-d5, Sintrom-d5)

3489.93 €

D231662

Denatonium-d5 Benzoate (benzyl-2,3,4,5,6-d5)

1369.56 €